HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Dose-response and mechanism of protective functions of selective alpha-2 agonist dexmedetomidine on acute lung injury in rats.

AbstractOBJECTIVE:
To investigate the protective functions of dexmedetomidine on lipopolysaccharide-induced acute lung injury in the lung tissues of rats.
METHODS:
The experiment was conducted from May 2008 to December 2009 in Zhongshan Hospital, Shanghai, China. Forty Sprague Dawley rats were randomized into a normal group (NS group), a lipopolysaccharide model group (LPS group), and dexmedetomidine groups in high dosages (HD), moderate dosages (MD), and low dosages (LD). After the acute lung injury model was duplicated by lipopolysaccharide, the rats in the LD, MD, and HD groups were injected with 0.5 ug/kg, 1.5 ug/kg, and 4.5 ug/kg of dexmedetomidine. The rats in the NS group were injected with normal saline. Immuno-histochemical and reverse transcription polymerase chain reaction techniques were used to assess the damage of lung tissue in each group.
RESULTS:
The nuclear factor-KappaB and Toll-like receptor 4 messenger RNA expression in the lung tissues of the rats in the MD and HD groups were inhibited compared to the LPS group. The amount of tumor necrosis factor-beta, interleukin-1beta, and interleukin-6 as well as the lung tissue wet to dry weight ratio were also reduced in the MD and HD groups.
CONCLUSION:
The inflammatory reactions in lung tissues can be effectively inhibited at doses ranging from 1.5-4.5 ug/kg, resulting in a protective effect on lung tissue.
AuthorsQi-Qing Shi, Hao Wang, Hao Fang
JournalSaudi medical journal (Saudi Med J) Vol. 33 Issue 4 Pg. 375-81 (Apr 2012) ISSN: 1658-3175 [Electronic] Saudi Arabia
PMID22485231 (Publication Type: Journal Article)
Chemical References
  • Adrenergic alpha-Agonists
  • DNA Primers
  • Dexmedetomidine
Topics
  • Acute Lung Injury (prevention & control)
  • Adrenergic alpha-Agonists (therapeutic use)
  • Animals
  • Base Sequence
  • DNA Primers
  • Dexmedetomidine (therapeutic use)
  • Dose-Response Relationship, Drug
  • Female
  • Male
  • Polymerase Chain Reaction
  • Rats
  • Rats, Sprague-Dawley

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: